Status:
NOT_YET_RECRUITING
Prospective Observational Study on ES-SCLC
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Extensive-stage Small-cell Lung Cancer
Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Study Title: A Real-World Study on Extensive-Stage Small Cell Lung Cancer (ES-SCLC) What is this study about? This research aims to learn more about how patients with extensive-stage small cell lung c...
Eligibility Criteria
Inclusion
- Aged 18 years or above
- Histologically or cytologically confirmed diagnosis of small cell lung cancer, classified as extensive stage (AJCC 9th Edition Stage IV).
- Signed informed consent, good compliance, and willingness to undergo treatment and follow-up.
- Intended to receive any anticancer treatment, including chemotherapy or immunotherapy.
Exclusion
- Lack of definitive histological diagnosis
- Patients with limited-stage small cell lung cancer
- Expected survival \< 3 months
- Inability to undergo regular follow-up.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT07173946
Start Date
September 1 2025
End Date
December 1 2028
Last Update
September 15 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.